|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schulman S: Advantages and limitations of
the new anticoagulants. J Intern Med. 275:1–11. 2014. View Article : Google Scholar
|
|
4
|
Mungall D: rNAPc2. Nuvelo Curr Opin
Investig Drugs. 5:327–333. 2004.
|
|
5
|
Schulman S: Patient self-management of
anticoagulants reduced arterial thromboembolism and adverse
effects. ACP J Club. 143:82005.PubMed/NCBI
|
|
6
|
Vlasuk GP, Bradbury A, Lopez-Kinninger L,
Colón S, Bergum PW, Maki S and Rote WE: Pharmacokinetics and
anticoagulant properties of the factor VIIa-tissue factor inhibitor
recombinant Nematode Anticoagulant Protein c2 following
subcutaneous administration in man. Dependence on the
stoichiometric binding to circulating factor X. Thromb Haemost.
90:803–812. 2003.PubMed/NCBI
|
|
7
|
Lee AY and Vlasuk GP: Recombinant nematode
anticoagulant protein c2 and other inhibitors targeting blood
coagulation factor VIIa/tissue factor. J Intern Med. 254:313–321.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moons AH, Peters RJ, Bijsterveld NR, Piek
JJ, Prins MH, Vlasuk GP, Rote WE and Büller HR: Recombinant
nematode anticoagulant protein c2, an inhibitor of the tissue
factor/factor VIIa complex, in patients undergoing elective
coronary angioplasty. J Am Coll Cardiol. 41:2147–2153. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hembrough TA, Swartz GM, Papathanassiu A,
Vlasuk GP, Rote WE, Green SJ and Pribluda VS: Tissue factor/factor
VIIa inhibitors block angiogenesis and tumor growth through a
nonhemostatic mechanism. Cancer Res. 63:2997–3000. 2003.PubMed/NCBI
|
|
10
|
Zhao J, Aguilar G, Palencia S, Newton E
and Abo A: rNAPc2 inhibits colorectal cancer in mice through tissue
factor. Clin Cancer Res. 15:208–216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raghu H, Nalla AK, Gondi CS, Gujrati M,
Dinh DH and Rao JS: uPA and uPAR shRNA inhibit angiogenesis via
enhanced secretion of SVEGFR1 independent of GM-CSF but dependent
on TIMP-1 in endothelial and glioblastoma cells. Mol Oncol.
6:33–47. 2012. View Article : Google Scholar :
|
|
12
|
Zhang Y, Kenny HA, Swindell EP, Mitra AK,
Hankins PL, Ahn RW, Gwin K, Mazar AP, O’Halloran TV and Lengyel E:
Urokinase plasminogen activator system-targeted delivery of
nanobins as a novel ovarian cancer therapy. Mol Cancer Ther.
12:2628–2639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Offersen BV, Pfeiffer P, Andreasen P and
Overgaard J: Urokinase plasminogen activator and plasminogen
activator inhibitor type-1 in nonsmall-cell lung cancer: Relation
to prognosis and angiogenesis. Lung Cancer. 56:43–50. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shariat SF, Monoski MA, Andrews B, Wheeler
TM, Lerner SP and Slawin KM: Association of plasma urokinase-type
plasminogen activator and its receptor with clinical outcome in
patients undergoing radical cystectomy for transitional cell
carcinoma of the bladder. Urology. 61:1053–1058. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nowicki TS, Moscatello AL, Shin E, Schantz
S, Tiwari RK and Geliebter J: The urokinase plasminogen activator
system in metastatic papillary thyroid carcinoma: A potential
therapeutic target. J Clin Endocrinol Metab. 96:3062–3064. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kenny HA, Leonhardt P, Ladanyi A, Yamada
SD, Montag A, Im HK, Jagadeeswaran S, Shaw DE, Mazar AP and Lengyel
E: Targeting the urokinase plasminogen activator receptor inhibits
ovarian cancer metastasis. Clin Cancer Res. 17:459–471. 2011.
View Article : Google Scholar :
|
|
17
|
Zhou H, Tang Y, Liang X, Yang X, Yang J,
Zhu G, Zheng M and Zhang C: RNAi targeting urokinase-type
plasminogen activator receptor inhibits metastasis and progression
of oral squamous cell carcinoma in vivo. Int J Cancer. 125:453–462.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gondi CS, Lakka SS, Dinh DH, Olivero WC,
Gujrati M and Rao JS: Intraperitoneal injection of a hairpin
RNA-expressing plasmid targeting urokinase-type plasminogen
activator (uPA) receptor and uPA retards angiogenesis and inhibits
intracranial tumor growth in nude mice. Clin Cancer Res.
13:4051–4060. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tummalapalli P, Gondi CS, Dinh DH, Gujrati
M and Rao JS: RNA interference-mediated targeting of urokinase
plasminogen activator receptor and matrix metalloproteinase-9 gene
expression in the IOMM-lee malignant meningioma cell line inhibits
tumor growth, tumor cell invasion and angiogenesis. Int J Oncol.
31:5–17. 2007.PubMed/NCBI
|
|
20
|
Bauer TW, Liu W, Fan F, et al: Targeting
of urokinase plasminogen activator receptor in human pancreatic
carcinoma cells inhibits c-Met- and insulin-like growth factor-I
receptor-mediated migration and invasion and orthotopic tumor
growth in mice. Cancer Res. 65:7775–7781. 2005.PubMed/NCBI
|
|
21
|
Hatfield GW and Roth DA: Optimizing
scaleup yield for protein production: Computationally Optimized DNA
Assembly (CODA) and Translation Engineering. Biotechnol Annu Rev.
13:27–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stevenson JL, Choi SH and Varki A:
Differential metastasis inhibition by clinically relevant levels of
heparins - correlation with selectin inhibition, not antithrombotic
activity. Clin Cancer Res. 11:7003–7011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Verso M and Agnelli G: New and old
anticoagulants in cancer. Thromb Res. 129(Suppl 1): S101–S105.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nalla AK, Asuthkar S, Bhoopathi P, Gujrati
M, Dinh DH and Rao JS: Suppression of uPAR retards
radiation-induced invasion and migration mediated by integrin
β1/FAK signaling in medulloblastoma. PLoS One. 5:e130062010.
View Article : Google Scholar
|
|
25
|
Moreau M, Mourah S and Dosquet C:
β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in
cancer cells. Int J Cancer. 128:1280–1292. 2011. View Article : Google Scholar
|
|
26
|
Gyrd-Hansen M and Meier P: IAPs: From
caspase inhibitors to modulators of NF-kappaB, inflammation and
cancer. Nat Rev Cancer. 10:561–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aurora AB, Biyashev D, Mirochnik Y,
Zaichuk TA, Sánchez-Martinez C, Renault MA, Losordo D and Volpert
OV: NF-kappaB balances vascular regression and angiogenesis via
chromatin remodeling and NFAT displacement. Blood. 116:475–484.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Castro-Gamero AM, Borges KS, da Silva
Silveira V, Lira RC, de Paula Gomes Queiroz R, Valera FC, Scrideli
CA, Umezawa K and Tone LG: Inhibition of nuclear factor-κB by
dehydroxymethylepoxyquinomicin induces schedule-dependent
chemosensitivity to anticancer drugs and enhances chemoinduced
apoptosis in osteosarcoma cells. Anticancer Drugs. 23:638–650.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hunter JE, Willmore E, Irving JA,
Hostomsky Z, Veuger SJ and Durkacz BW: NF-κB mediates
radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene.
31:251–264. 2012. View Article : Google Scholar
|
|
30
|
Truhlar SM, Torpey JW and Komives EA:
Regions of IkappaB alpha that are critical for its inhibition of
NF-kappaB. DNA interaction fold upon binding to NF-kappaB. Proc
Natl Acad Sci USA. 103:18951–18956. 2006. View Article : Google Scholar
|
|
31
|
Tacchini L, Matteucci E, De Ponti C and
Desiderio MA: Hepatocyte growth factor signaling regulates
transactivation of genes belonging to the plasminogen activation
system via hypoxia inducible factor-1. Exp Cell Res. 290:391–401.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Min HJ, Lee Y, Zhao XF, Park YK, Lee MK,
Lee JW and Kim S: TMPRSS4 upregulates uPA gene expression through
JNK signaling activation to induce cancer cell invasion. Cell
Signal. 26:398–408. 2014. View Article : Google Scholar
|
